research should identify specific strategies and interventions that improve the value and efficiency of care. ... said. Critical care physicians vary widely in their estimates of ICU benefit, according to a recent study.
increased the rate of major bleeding complications, a recent industry-funded study found. ... Procalcitonin can help guide antibiotic management, including when to discontinue therapy, in ICU patients, a recent meta-analysis found.
There is an increased risk of ischemic stroke for up to two years after a hospitalization for infective endocarditis, a recent study found. ... Patients and their surrogates often disagree with clinicians about appropriateness of ICU treatment, leading
long-term clinical outcomes after acute myocardial infarction (MI), a recent study suggested. ... Procalcitonin values demonstrated accuracy in differentiating viral from bacterial community-acquired pneumonia (CAP) in a recent study, but not at
Identifying the highest-quality, most cost-effective nursing home in the area probably isn't tops on your to-do list, but experts and recent research suggest that setting up systems
The pneumococcal urinary antigen test can effectively help guide drug selection to treat community-acquired pneumonia (CAP) in the hospital, according to a recent study. ... Stopping aspirin less than six days before CABG did not change patients'
an increased incidence of portal-vein thrombosis, according to a recent industry-funded study. ... MI risk, or risk of MI or vascular death, for recent stroke patients, the authors wrote.
Comprehensive geriatric assessment of older adults appears to improve hospital survival, a recent study indicates. ... Patients were about equally satisfied when they were cared for by hospitalists or primary care physicians, a recent study found.
A recent study validated the IMPROVE score for predicting bleeding risk in inpatients and guiding venous thromboembolism prophylaxis. ... Future research should look for additional predictors of bleeding and identify thresholds for administering or
Future research should combine this rule-out strategy with assessment of risk factors and symptoms, the authors suggested. ... Ularitide, an intravenous synthetic form of the renal vasodilatory natriuretic peptide urodilatin, did not improve mortality